首页> 外文OA文献 >Sensitive, Color-Indicating and Labeling-Free Multi-Detection Cholesteric Liquid Crystal Biosensing Chips for Detecting Albumin
【2h】

Sensitive, Color-Indicating and Labeling-Free Multi-Detection Cholesteric Liquid Crystal Biosensing Chips for Detecting Albumin

机译:敏感,颜色指示和无标记的多检测胆甾型液晶生物腐肉芯片用于检测白蛋白

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A novel device for cholesteric liquid crystal (CLC)-based microfluidic chips, accommodated in a polydimethylsiloxane material, was invented. In this device, the reorientation of the CLCs was consistently influenced by the surface of the four channel walls and adjacent CLCs. When the inside of the microchannel was coated with the alignment layer, the CLCs oriented homeotropically in a focal conic state under cross-polarizers. Once antigens had bound onto antibodies immobilized onto the orientation sheet-coated channel walls, the light intensity of the CLC molecules converted from a focal conic state to a bright planar state caused by disrupting the CLCs. By means of utilizing pressure-propelling flow, the attachment of antigen/antibody to the CLCs should be detectable within consecutive sequences. The multi-microfluidic CLC-based chips were verified by measuring bovine serum albumin (BSA) and immune complexes of pairs of BSA antigen/antibody. We showed that the multiple microfluidic immunoassaying can be used for measuring BSA and pairs of antigen/antibody BSA with a detection limit of about 1 ng/mL. The linear range is 0.1 μg/mL–1 mg/mL. A limit of immune detection of pairs of BSA antigens/antibodies was 10 ng/mL of BSA plus 1000 ng/mL of the anti-BSA antibodies was observed. According to this innovative creation of immunoassaying, an unsophisticated multi-detection device with CLC-based labeling-free microfluidic chips is presented.
机译:发明了一种用于胆甾型液晶(CLC)的微流体芯片,其容纳在聚二甲基硅氧烷材料中的一种新型装置。在该装置中,CLC的重新定向由四个通道壁和相邻CLC的表面始终受到影响。当微通道内部涂覆有取向层时,CLC在交叉偏振器下在焦点锥体状态下定向。一旦抗原结合到固定在取向片涂覆的通道壁上的抗体上,CLC分子的光强度从焦点锥体转换为通过破坏CLC而引起的明亮平面状态。通过利用压力推进的流动,应在连续序列内检测抗原/抗体对CLC的附着。通过测量牛血清白蛋白(BSA)和对BSA抗原/抗体对的免疫复合物来验证基于多微流体CLC的芯片。我们表明,多种微流体免疫测定可用于测量BSA和对抗原/抗体BSA的检测限为约1ng / mL。线性范围为0.1μg/ ml-1mg / ml。对BSA抗原/抗体对的免疫检测的极限为10ng / ml BSA加1000ng / ml抗BSA抗体。根据这种创新的免疫测定创造,提出了一种不足的多检测装置,其具有基于CLC的无标记的微流体芯片。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号